--News Direct--
Rodedawg International Industries, Inc. (OTC: RWGI) Inc. proudly announces its expansion into the healthcare industry with the purchase of Elixicure™ Pain Relief. Chris Swartz, CEO of Rodedawg states, “We are very proud to announce to our shareholders that Rodedawg has acquired Elixicure™ and all its assets. Our shareholders are benefitting from the roadmap of 6 years of healthcare marketing experience and the evolution of the Elixicure™ brand. The Elixicure™ team raised over 3 and ½ million dollars and we are acquiring not only physical production equipment but we are gaining years of research, finalized formulas, packaging, branding, brand awareness and established revenue producing sales channels. The acquisition includes manufacturing equipment, transportation and warehouse equipment, sales personnel and sales channels with growing revenue streams. In its first few years of operation the company expanded exponentially and generated close to 1 million in revenues within 3 years of its start. The product set is already embedded in regional sports culture and has been a great success in chiropractic and healthcare centers. Rodedawg personnel will be adding to the management team and we fully expect to see Elixicure™ generate over 3 million in its first year as a Rodedawg company. This acquisition gives Rodedawg an the entrance into the multi-billion dollar pain relief market.”
Chris Swartz, CEO, adds, “According to Allied Market Research, the global topical pain relief market size was valued at $8.8 billion in 2019, and is projected to reach $12.2 billion by 2027 at a CAGR of 5.2% from 2020 to 2027. This is a massive market and this acquisition positions the company to expand into products and services generating revenue streams back to the Rodedawg enterprise. Until the SAFE Banking ACT and national legalization of cannabis, this acquisition allows Rodedawg to develop channels of distributions with marketing and sales of products in mainstream national markets. Additionally, we will also be informing our shareholders of our expanded sales and marketing plan for Elixicure™ and a wide range of health care products with multi-faceted distribution sales channels.”
Mr. Swartz concludes, “In the next few weeks, management will further inform shareholders on the timeframe and progress of accomplishing success milestones to further expand shareholder value. Behind the scenes, we are lining up additional acquisitions, cancellation of shares, and completion of our audit, as our plan from the beginning has been positioning the Company for significant growth leading to uplisting.”
About Rodedawg International Industries, Inc.
Rodedawg International Industries, Inc. (OTC: RWGI) is focused on providing management services, acquisitions, and restructuring resources throughout the regulated California cannabis market. We are a trusted partner and asset to licensed cultivation, distributors, manufacturers, and retail dispensaries
Please note, the company's Twitter address is https://twitter.com/RWGImerger for regular updates.
About Elixicure™
Elixicure™ Pain Relief creates, manufacturers and distributes high quality, organic pain relief without chemical additives. Founded in 2017 by two brothers who made it their mission to help their mother and the world by creating the best natural pain relief.
The company website is https://elixicure.com/
Social Channels include:
Facebook: https://www.facebook.com/Elixicure/
Instagram: https://www.instagram.com/elixicure/?hl=en
https://www.youtube.com/channel/UC0FbyKmTYOxs6UTU_04F-mQ
Purchase Online with Walmart at https://www.walmart.com/ip/Elixicure-All-Natural-Pain-Relief-Cream-Roll-on-Lavender-Scent
Purchase Online with Amazon at https://www.amazon.com/Elixicure-Pain-Relief
About Budding Horizon, LLC
Budding Horizon, LLC is a California Limited Liability Company with offices in Orange County, California. The company is focused to providing management services for the licensed cannabis portfolio of assets.
The company website is https://buddinghorizon.com/
Contact Information:
Rodedawg International Industries, Inc.
1-800-793-0355
Safe Harbor Statement: In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE: Rodedawg International Industries, Inc.
Contact Details
Rodedawg International Industries, Inc
View source version on newsdirect.com: https://newsdirect.com/news/rodedawg-intl-ind-inc-otc-rwgi-expands-into-healthcare-with-acquisition-of-elixicure-pain-relief-180058081
